Table 4.
Authors | Characteristic of the Group | Ashwagandha Formulation Characteristics | Duration of the Observation | Results | References |
---|---|---|---|---|---|
Baghel et al. | 18 sexually mature six weeks old male Japanese quail as a animal model of infertility, provoked by using photoperiodic chambers | 100 mg/day/kg of W. Somnifera root extract; oral administraion |
few months of inducing infertility using photoperiodic chambers and 45 days of Ashwagandha administration | ↑expression of estrogen receptor alpha ↑estrogen ↓corticosterone |
[51] |
Megahd et al. | 50 adult female rats; model of H2O2-induced utero-ovarian oxidative injury and cell death, what caused reduction in serum level of FSH, LH, progesterone, and estrogen compared to a healthy control group |
200 mg/kg Ashwagandha tea extract; oral administraion |
1 month | ↑FSH ↑LH ↑progesterone ↑estrogen -significantly restored estrous cycle length |
[52] |
Ajgaonkar et al. | prospective, randomized, placebo-controlled study; 80 women, 18–50 years old, without any hormonal disturbances and having hypoactive sexual desire disorder (HSDD) with a Female Sexual Function Index (FSFI) score < 26, or Female Sexual Distress Scale (FSDS) score > 11 | 300 mg of standardized Ashwagandha root extract twice daily; oral administraion |
8 weeks | -improvement in sexual functions | [14] |
Chauhan et al. | randomized, controlled trial; 50 healthy male subjects with low sexual desire | 300 mg of Ashwagandha root extract twice daily; oral administraion |
8 weeks | ↑testosterone -improvement of sexual functions measured by DISF-M |
[49] |